Celine Gavoille

Nancy, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Cyclin E1 overexpression identifies a therapeutically relevant poor prognostic patient subgroup in high-grade serous ovarian cancer.

Cyclin E1 overexpression identifies a therapeutically relevant poor prognostic patient subgroup in high-grade serous ovarian cancer.

Journal: NPJ precision oncology

Published: November 21, 2025

Sensitive cell-free DNA assay for accurate detection of RAS and BRAF mutations in liquid biopsies of patients with metastatic colorectal cancer: Final results of the multicentric ColoBEAM study.

Sensitive cell-free DNA assay for accurate detection of RAS and BRAF mutations in liquid biopsies of patients with metastatic colorectal cancer: Final results of the multicentric ColoBEAM study.

Journal: Oncology letters

Published: February 21, 2025

Impact of Electronic Transition and Prefilled Templates on Drug Prescription Compliance: Retrospective Study.

Impact of Electronic Transition and Prefilled Templates on Drug Prescription Compliance: Retrospective Study.

Journal: Journal of medical Internet research

Published: February 26, 2024

Real-World Data on Olaparib in Relapsed BRCA-mutated Ovarian Cancer: A Multicenter GINECO RETROLA Cohort Study.

Real-World Data on Olaparib in Relapsed BRCA-mutated Ovarian Cancer: A Multicenter GINECO RETROLA Cohort Study.

Journal: Anticancer research

Published: September 05, 2022

A phase II study of Navitoclax (ABT-263) as single agent in women heavily pretreated for recurrent epithelial ovarian cancer: The MONAVI - GINECO study.

A phase II study of Navitoclax (ABT-263) as single agent in women heavily pretreated for recurrent epithelial ovarian cancer: The MONAVI - GINECO study.

Journal: Gynecologic oncology

Published: November 22, 2021

Association of COVID-19 Lockdown With the Tumor Burden in Patients With Newly Diagnosed Metastatic Colorectal Cancer.

Association of COVID-19 Lockdown With the Tumor Burden in Patients With Newly Diagnosed Metastatic Colorectal Cancer.

Journal: JAMA network open

Published: September 08, 2021

Evaluation of KRAS, NRAS and BRAF mutations detection in plasma using an automated system for patients with metastatic colorectal cancer.

Evaluation of KRAS, NRAS and BRAF mutations detection in plasma using an automated system for patients with metastatic colorectal cancer.

Journal: PloS one

Published: August 19, 2019

Intrapericardial instillation of bleomycin prevents recurrence of malignant pericardial effusions: Series of 46 cases and comprehensive literature review.

Intrapericardial instillation of bleomycin prevents recurrence of malignant pericardial effusions: Series of 46 cases and comprehensive literature review.

Journal: Bulletin du cancer

Published: February 25, 2019

Exploitation of Precision Medicine Trials Data: Examples of Long Responders From the SHIVA01 Trial.

Exploitation of Precision Medicine Trials Data: Examples of Long Responders From the SHIVA01 Trial.

Journal: JCO precision oncology

Published: October 19, 2018

Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment.

Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 16, 2017

Current status on the place of FOLFIRINOX in metastatic pancreatic cancer and future directions.

Current status on the place of FOLFIRINOX in metastatic pancreatic cancer and future directions.

Journal: Therapeutic advances in gastroenterology

Published: February 15, 2017

Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial.

Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: December 21, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026